Office for shareholder information
Biosearch life's web page will therefore become an official site containing up-to-date information for shareholders and for the trade market in general. For this purpose, the company has created an office for shareholders to obtain relevant information regarding the company.
Office for shareholder information:
BIOSEARCH, S.A. Camino de Purchil, nº66 - 18004 Granada
Contact person: Loreto Huertas
Opening hours: 9.00 - 14.00h
Telephone +34 958 240 200
PAO
Share capital
General Stock Market negotiation data BIOSEARCH S.A. Issuer 72233 NIF: A18550111.
Address: Camino de Purchil, 66 C.P. 18004 GRANADA ISIN: ES0172233118
Ticker: BIO
Sector: Biotecnología
Nominal: 0,24 euros
Number of shares: 57.699.522
Admitted capital: 13.847.885,28 euros
Markets: Madrid, Barcelona, Valencia and Bilbao
Market segment: SIBE Segmento Nuevo Mercado
Incorporation SIBE: 17/12/2001
Share Capital structure
Currently, BIOSEARCH, S.A., share capital amounts to 13,847,885.28 Euros and is fully subscribed and paid-up
Investor's Calendar
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Dividends
Up to now no dividend has been released.
Issues
ACCORDING TO THE STATUTES REGISTERED IN THE MERCANTIL REGISTRY DATED FEBRUARY 5, 2016
Stock market news
The Company guarantees that the significant events published on this web page correspond exactly to those sent to the National Securities Market Commission (CNMV).
The significant events prior to 2012 are available for consultation on the website of the CNMV.
2020
Biosearch S.A. applies for a patent for use in the treatment of cognitive disorders
2019
CDTI financing grant for the new R&D project for elderly pathologies
Biosearch communicates the handout regarding third quarter results of 2019
Biosearch publishes results for the third quarter of 2019
Biosearch announces Variations in the composition of the Board of Directors
Biosearch invests 700 thousand euros in a new R&D project for pathologies of the elderly.
The Company publishes results for first half of 2019
Biosearch, S.A. communicates the resolutions approved by the Ordinary General Shareholders' Meeting held on 26 June 2019
Biosearch communicates the convening of the general meeting of shareholders 2019
The Company publishes results for the first quarter of 2019
The company communicates a remuneration system linked to compliance of the strategic plan 2018-2020
Biosearch sends the Annual Report on remunerations of the counselors of the Exercise 2018
The company sends the Annual Report of Corporate Government of the exercise 2018
Results for the year-end 2018
2018
Biosearch S.A., communicates changes in the composition of the Board of Directors
The Company publishes results for the third quarter of 2018
The Company publishes results for first half of 2018
Biosearch, S.A. signs an agreement with Nestlé for the license of "Hereditum Lactobacillus fermentum LC40®"
The Company communicates the agreements adopted by The General meeting of shareholders 2018
Biosearch communicates the convening of the general meeting of shareholders 2018
The Company publishes results for the first quarter of 2018
Biosearch sends the Annual Report on remunerations of the counselors of the Exercise 2017
The company sends the Annual Report of Corporate Government of the exercise 2017
The company publishes results for the second half of 2017
2017
Biosearch, S.A. signs an agreement with Nestlé for the license of "Hereditum Lactobacillus fermentum LC40®"
The Company publishes results for the third quarter of 2017
Biosearch S.A., communicates changes in the composition of the Board of Directors
The Company publishes results for first half of 2017
The Company communicates the agreements adopted by The General meeting of shareholders 2017
The Company publishes results for the first quarter of 2017
Biosearch communicates the convening of The General meeting of shareholders 2017
Biosearch, S.A. sends the annual audited accounts corresponding to the social exercise closed on December 31, 2016.
The company sends the Annual Report of Corporate Government of the exercise 2016
The Company sends the Annual Report on remunerations of the counselors of the Exercise 2016
BIOSEARCH S.A COMUNICATES CHANGES IN THE VALUATION OF ITS ACTIVE AND PASSIVE WITH THE ASJUSTMENT OF GOODWILL VALUE OF THE BUSINESS OF EXTRACTS.
THE COMPANY PUBLISHES RESULTS FOR SECOND HALF OF 2016
Biosearch S.A. communicates changes in the composition of the board of directors
2016
Biosearch S.A publishes results for third quarter of 2016
The Company publishes results for first half of 2016
The Company sends the Annual Report on remunerations of the counselors of the Exercise 2015
The company sends the Annual Report of Corporate Government of the exercise 2015
Biosearch S.A publishes results for first quarter of 2016
Biosearch, S.A sends the annual audited accounts corresponding to the social exercise closed on December 31, 2015.
Biosearch publishes results for second half of 2015
2015
Biosearch S.A, publishes results for the third quarter of 2015
Biosearch S.A., communicates changes in the composition of the Board of Directors
The Company publishes results for first half of 2015
The Company publishes results for the first quarter of 2015
The Company communicates the agreements adopted by The General meeting of shareholders 2015
Biosearch S.A, communicates the convening of The General meeting of shareholders 2015
The company sends the Annual Report of Corporate Government of the exercise 2014.
The Company sends the Annual Report on remunerations of the counselors of the Exercise 2014
The Company publishes results for second half of 2014
2014
Biosearch S.A., communicates changes in the composition of the Board of Directors
Biosearch S.A., communicates changes in the composition of Executive Commission
The Company publishes results for the third quarter of 2014
The Company publishes results for first half of 2014
Biosearch S.A., communicates changes in the composition of the Board of Directors
The Company communicates the agreements adopted by The General meeting of shareholders 2014
Biosearch S.A, publishes results for the third quarter of 2014
Biosearch S.A, communicates the convening of The General meeting of shareholders 2014
The Company sends the Annual Report on remunerations of the counselors of the Exercise 2013
The Company sends the formulation of annual accounts for the year ending December 31, 2013
Biosearch S.A., publishes results for second half of 2013
2013
Biosearch S.A, finishes successfully the process of refunding of his financial debt.
Biosearch S.A, publishes results for the third quarter of 2013
The Company publishes results for first half of 2013
Biosearch S.A, communicates the request of a patent
The Company communicates the agreements adopted by The General meeting of shareholders 2013
Biosearch S.A, communicates the convening of The General meeting of shareholders 2013
The Company publishes results for the first quarter of 2013
Biosearch S.A, communicates the formulation of annual accounts of the 2012
The Company publishes results for second half of 2012
2012
The Company publishes results for the third quarter of 2012
The Company publishes the results of first half of 2012
Biosearch, S.A. communicates changes in the Board of Directors
The Company sends the results of the first quarter of 2012
The Company reports variations in the composition of the Board of Directors
The Company gives information on the results of the second half of 2011
The significant events prior to 2012 are available for consultation on the website of the CNMV
Privileged information
2021
Communication from Pescaderías Coruñesas on the PAO
Attached report to the communication of privileged information of the past day 06/08/2021
Report approved by the Board of Directors of Biosearch, S.A. in relation to the OPA formulated by Kerry Iberia Taste & Nutrition, S.L.U.
Press release on the results achieved by Biosearch, S.A. in the year 2020
Biosearch, S.A. announces results for the second half of fiscal year 2020
2020
Press release on the results of the 3rd quarter of 2020
Biosearch, S.A. publishes sales for the first half of 2020
Biosearch S.A. applies for a new international patent for the treatment of female infertility.
BIOSEARCH LAUNCHES A CLINICAL TRIAL OF ITS PRODUCT HEREDITUM® IMMUNACTIV K8 ON HEALTHCARE PERSONNEL IN CONTACT WITH COVID-19 PATIENTS
BIOSEARCH APPLIES FOR TWO INTERNATIONAL PATENTS,ONE FOR THE PREVENTION OF CARDIOVASCULAR DISEASES AND THE OTHER FOR THE PREVENTION OF VAGINAL INFECTIONS
The company reports on its business performance and the measures adopted to COVID-19
Other relevant information
2021
Biosearch S.A. announces the changes in the composition of the Board of Directors of Biosearch, S.A.
Biosearch communicates the convening of the General Meeting of Shareholders 2021
The Company communicates the results of the first quarter of 2021
The Company submits the regulations of the Board of Directors
The company sends the Annual Report of Corporate Government of the exercise 2020
Biosearch sends the Annual Report on remunerations of the counselors of the Exercise 2020
Changes in the composition of the Audit, Control and Conflicts of Interest Committee of Biosearch, S.A.
Biosearch, S.A. forward the financial information of the 2nd half of 2020
2020
Biosearch communicates Internal regulations of conduct in matters of the securities market
Results for the third quarter of 2020
Composition of the Board of Directors and its committees
Biosearch communicates the convening of the general meeting of shareholders 2020
Complement to the announcement of the call of the Ordinary General Shareholders Meeting
Biosearch communicates the convening of the general meeting of shareholders 2020
The Company publishes results for the first quarter of 2020
Biosearch, S.A. announces the press release regarding the results of the first quarter of 2020
The company sends the Annual Report of Corporate Government of the exercise 2019
Biosearch sends the Annual Report on remunerations of the counselors of the Exercise 2019
Biosearch communicates the handout regarding second half results of 2019
Biosearch presents the results for 2019
Biosearch, S.A. forward the financial information of the 2nd half of 2019
Para-corporate pacts
Participating companies
Biosearch S.A, has no significant participation in other companies
Treasury stock
BIOSEARCH, S.A.
Capital 13,847,885.28 (Euros)
On December 31, 2017, the company holds 5,621 titles in treasury stock
by J.M Roset, Managing Director